CRISM Therapeutics Corp (CRTX) NPV

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Crism Therapeutics gets clearance for UK phase 2 trial
1 September 2025 14:54
(Sharecast News) - Crism Therapeutics said on Monday that it has received both regulatory clearance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) and ethical approval from a UK...
-
Crism reports progress with ChemoSeed drug delivery platform
26 August 2025 11:02
(Sharecast News) - Crism Therapeutics used its annual general meeting on Tuesday to highlight progress on its ChemoSeed drug delivery platform as it advances towards key clinical milestones.
Company announcements Announcements
-
Notice of Interim Results and IMC Presentation
12 September 2025 07:00
Crism Therapeutics Corporation Ord Npv
-
Approval for phase 2 clinical trial
1 September 2025 07:00
Crism Therapeutics Corporation Ord Npv
-
Result of AGM
26 August 2025 16:03
Crism Therapeutics Corporation Ord Npv
-
AGM Statement
26 August 2025 07:00
Crism Therapeutics Corporation Ord Npv
-
GMP Manufacture of ChemoSeed
12 August 2025 07:00
Crism Therapeutics Corporation Ord Npv
-
Notice of AGM and EMI Option Plan
4 August 2025 17:45
Crism Therapeutics Corporation Ord Npv
-
Holding(s) in Company
10 July 2025 15:04
Crism Therapeutics Corporation Ord Npv
-
Result of Retail Offer and Additional Placing
3 July 2025 07:00
Crism Therapeutics Corporation Ord Npv
-
Update presentation on the IMC platform
1 July 2025 16:41
Crism Therapeutics Corporation Ord Npv
-
Submission of CTA Application
1 July 2025 07:00
Crism Therapeutics Corporation Ord Npv
-
Retail Offer
30 June 2025 07:01
Crism Therapeutics Corporation Ord Npv
-
Placing
30 June 2025 07:00
Crism Therapeutics Corporation Ord Npv
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.